Linear parameter varying (LPV) based robust control of type-I diabetes driven for real patient data by Kovács, Levente
Knowledge-Based Systems 122 (2017) 199–213 
Contents lists available at ScienceDirect 
Knowle dge-Base d Systems 
journal homepage: www.elsevier.com/locate/knosys 
Linear parameter varying (LPV) based robust control of type-I diabetes 
driven for real patient data 
Levente Kovács 
Physiological Controls Research Center, University Research and Innovation Center, Óbuda University John von Neumann Faculty of Informatics, 
Óbuda University Bécsi út 96/b, H-1034 Budapest, Hungary 
a r t i c l e i n f o 
Article history: 
Received 15 September 2016 
Revised 5 February 2017 
Accepted 7 February 2017 
Available online 7 February 2017 
Keywords: 
Modern robust control 
H ∞ control 
LPV modeling 
Nonlinearity 
Type 1 diabetes 
a b s t r a c t 
Due to increasing prevalence of diabetes as well as increasing management costs, the artiﬁcial control 
of diabetes is a highly important task. Model-based design allows ﬁnding more effective solutions for 
the individual treatment of diabetic patients, but robustness is an important property that can be hardly 
guaranteed by the already developed individualized control algorithms. Modern robust control (known as 
H ∞ ) theory represents an eﬃcient possibility to solve robustness requirements in a general way based 
on exact mathematical formulation (Linear Matrix Inequalities) combined with knowledge-based exper- 
tise (through real patient data, uncertainty weighting functions can be formulated). When the difference 
between the nominal model and real patient dynamics is bounded and known, this approach becomes 
highly reliable. However, this requirement poses the greatest limitation since a model always represents 
an approximation of the complex physiological process. Consequently, the uncertainty formulation of the 
neglected dynamics becomes crucial as robust methods are very sensitive to them. In order to formulate 
them, large amount of real patient data and medical expertise is needed to cover the different life-style 
scenarios (especially the worst-case ones) that deﬁne the control space by the accumulated knowledge. 
On the other hand, H ∞ –based methods represent linear control techniques; hence their direct nonlinear 
application is important for a physiological process. The paper presents a roadmap of using modern ro- 
bust control in diabetes focusing on nonlinear model-based interpretation: how the weighting functions 
should be selected based on (knowledge-based) medical expertise, the direct nonlinear applicability of 
the method taking additional advantage of the recently emerged Linear Parameter Varying (LPV) method- 
ology, robust performance investigation and switching control possibilities. During the control character- 
istics discussion, the trade-off between the medical knowledge-based empiricism and exact control engi- 
neering formulation is introduced through different examples computed under MATLAB on real diabetic 
patient data. 
© 2017 The Author. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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0. Introduction 
.1. Diabetes modeling and control. Artiﬁcial pancreas 
Glucose is the primary source of energy of the human body.
he blood glucose level is kept in a narrow range (3.9–6 mmol/L or
0–110 mg/dL) by the complex endocrine system and insulin plays
 key role in this process. When insulin secretion or insulin action
s impaired, diabetes is diagnosed [1] . 
Diabetes is named by the World Health Organization (WHO) as
he “disease of the future”, predicting that the number of diabetic
atients will be doubled from 20 0 0 to 2030 [2] . Recent statisticsE-mail address: kovacs.levente@nik.uni-obuda.hu 
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950-7051/© 2017 The Author. Published by Elsevier B.V. This is an open access article unpdated the forecast for the 2010–2030 period, but still a signif-
cant increase of the overall diabetes population is predicted [3] .
onsequently, the treatment of diabetes is of paramount impor-
ance. From engineering point of view, the treatment of diabetes
ellitus can be represented as a control problem to automatically
egulate the glucose-insulin balance. The problem is known as the
rtiﬁcial Pancreas (AP) [4] , investigated for type 1 diabetes melli-
us (T1DM), an autoimmune type of diabetes in which the pancre-
tic β-cells are completely destroyed (and, as a result, the treat-
ent requires glucose concentration measurements and subcuta-
eous insulin injections). The AP has three main components [5] : 
• Continuous Glucose Monitors (CGM) for the subcutaneous mea-
surement (with 5 minutes sampling time) of glucose concentra-
tion; der the CC BY-NC-ND license. ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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i  • Insulin pumps for the subcutaneous delivery of insulin; 
• Control algorithm that - based on CGM measurements - is able
to determine the necessary insulin dosage to be injected by the
insulin pumps. 
As sophisticated CGM and insulin pumps are available on the
market, the realization of an AP relies on control algorithm aspects
[6–7] . 
The control methods proposed in the literature are mostly
model-based [8] ; hence, an adequate mathematical model of the
human metabolism was needed. Different models appeared over
the last decades, starting with the oversimpliﬁed minimal model
[9] ; however, nowadays more complex models are considered for
describing the different compartments (at different levels of the
human body), the nonlinear physiological relation of the glucose-
insulin behavior, but taking the different time delays into ac-
count or including CGM models and subcutaneous insulin deliv-
ery models as well [10–12] . Although different control algorithms
have been proposed in the literature [4–8] , only four main con-
trol strategies reached AP prototype systems: Proportional Inte-
gral Derivative (PID) based controllers [13] , Model Predictive Con-
trol (MPC) [14–17] , run-to-run control [18] , and Fuzzy Logic based
controls [19] . The majority of the mentioned algorithms are able
to achieve nocturnal glucose regulation in an individualized man-
ner. MPC focuses on glucose trend estimations by minimizing the
difference between the predicted blood glucose level estimated in
a given time horizon (due to meal intakes this is usually in the
60–240 minutes interval) and the ideal glucose concentration. The
PID control idea relies on continuously adjusting the insulin in-
jection rate based on the main components of the classical con-
trol theory: proportional (based on real and ideal glucose level dif-
ference), integral (based on glucose trajectory area) and derivative
(based on glucose rate change) components. The fuzzy logic based
control creates a rule-based methodology. Although all the above
mentioned solutions require a considerable amount of expertise
converted into controller design requirements, robustness remains
a challenge in all the mentioned cases that should be separately
treated, discussed and implemented from the individualized con-
trol idea. Most importantly, the worst cases should be detected and
handled; these can be basically translated in avoiding the hypo-
glycemic episodes in case of diabetic patients. This requires a large
amount of measurement data not only to deﬁne the boundaries of
the control space, but to supplement the model inaccuracies which
are consequences of the unhandled dynamics and neglected uncer-
tainties. Consequently, the robust control problem can be deﬁned
as a mathematical problem largely depending on the accumulated
expertise gained from the measurements, i.e. a knowledge-based
control system. 
1.2. Modern robust control for T1DM 
Although the available T1DM models are all complex nonlin-
ear systems with slowly changing patient parameters over time,
the controller has to ensure safety and stability under all circum-
stances. This means that robustness should be guaranteed. More-
over, there are various constraints and speciﬁcations the controller
must address complicating the design even further. As the above
mentioned control algorithms give individualized solutions leav-
ing robustness a challenge, modern robust control methods seek to
provide safety generalized usability with worst case situations han-
dling guarantees. However, increasing robustness will limit track-
ing properties; hence a robust controller would be inferior to other
model-based methods on the nominal model [20] . 
For this reason, modern robust control, e.g. H ∞ robust controller
design can be most effectively used when working with uncertain
linear systems [20] with increasing tendency in medical applica-ions as well [21] . In particular, the applicability of this methodol-
gy in the T1DM problem has been investigated in [22–24] and the
ethod’s advantages have been highlighted in comparison with
ther control design methods [36–38] . However, a generally ap-
licable method does not exist for nonlinear models, where even
roving stability can be a diﬃcult task, and the problem gets more
omplicated under parameter inaccuracies, uncertainties and un-
odeled dynamics. 
The novelty of the current paper lies on a roadmap of the pos-
ibilities and diﬃculties implementing an H ∞ robust controller for
1DM. For this, one of the reference models of AP researches is
sed [14] , described in Section 2 . Section 3 discusses the con-
roller designing aspects. Using the linear parameter varying (LPV)
ethodology, the nonlinear model is transformed into a linear
ne without approximation (linearization). Hence, the linear H ∞ 
ontrol method could be applied on the original nonlinear T1DM
odel itself. Controllers with different structures and properties
re implemented to show robust structure construction particu-
arities, including the selection of weighting functions, robust per-
ormance investigation or switching control possibilities, consider-
tions that make the problem a knowledge-based controller design
ne. The eﬃciency of the obtained controllers is tested in Section
 using one of the reference in-silico simulators of the literature,
he University of Cambridge SimEdu simulator version 2.2 [25] ,
oncluding the results in Section 5 . 
. The investigated model 
The 11th order model introduced by [10] at Cambridge, UK, rep-
esents one of the mostly used T1DM model of the literature for
rtiﬁcial pancreas researches. Later it was updated by [25] leading
o University of Cambridge SimEdu simulator used in the current
esearch as well. The model can be described by the following dif-
erential equations: 
˙ C (t) = −k a, int C(t) + 
k a, int 
V G 
Q 1 (t) 
˙ 
 1 (t) = −
(
F s 01 
Q 1 (t) + V G 
+ x 1 (t) 
)
Q 1 (t) + k 12 Q 2 (t) 
−R cl max { 0 , Q 1 (t) − R th V G } 
+ EG P 0 max { 0 , 1 − x 3 (t) } + U G (t) − P hy (t) 
˙ 
 2 (t) = x 1 (t) Q 1 (t) − ( k 12 + x 2 (t) ) Q 2 (t) 
˙ x1 (t) = −k b1 x 1 (t) + S IT k b1 I(t) 
˙ x2 (t) = −k b2 x 2 (t) + S ID k b2 I(t) 
˙ x3 (t) = −k b3 x 3 (t) + S IE k b3 I(t) 
˙ I (t) = k a 
V I 
S 2 (t) − k e I(t) 
˙ S 2 (t) = −k a S 2 (t) + k a S 1 (t) 
˙ S 1 (t) = −k a S 1 (t) + u (t) (1)
here the state variables are: 
• C ( t ) the glucose concentration in the subcutaneous tissue
[mmol/L]; 
• Q 1 ( t ) and Q 2 ( t ) the masses of glucose in accessible and non-
accessible compartments [mmol]; 
• x 1 ( t ), x 2 ( t ) and x 3 ( t ) remote effect of insulin on glucose distribu-
tion, disposal and endogenous glucose production respectively
[1/min]; 
• I ( t ) insulin concentration in plasma [mU/L]; 
• S 1 ( t ) and S 2 ( t ) insulin masses in the accessible and non-
accessible compartments [mU]. 
The u ( t ) injected insulin ﬂow of rapid-acting insulin [mU/min]
s the input of the system, while the U ( t ) glucose ﬂux fromG 
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t  he gut [mmol/min], and the Phy ( t ) effect of physical activity
mmol/min] are considered as disturbances. 
The parameters of the model are as follows: 
• k a,int transfer rate constant between the plasma and the subcu-
taneous compartment [1/min]; 
• V G distribution volume of glucose in the accessible compart-
ment [L]; 
• F s 01 parameter of the total non-insulin dependent glucose ﬂux
[mmol/min]; 
• k 12 transfer rate constant from the non-accessible to the acces-
sible compartment [1/min]; 
• R cl renal clearance constant [1/min]; 
• R th glucose threshold [mmol/L]; 
• EGP 0 endogenous glucose production extrapolated to the zero
insulin concentration [mmol/min]; 
• k b1 and k b2 deactivation rate constants [L/(mU · min 2 )], k b3 de-
activation rate constant for the insulin effect on endogenous
glucose production [L/(mU · min )]; 
• S IT , S ID and S IE insulin sensitivities for transport, distribu-
tion and endogenous glucose production [L/(mU · min )] and
[L/(mU)]; 
• k a insulin absorption rate constant [1/min]; 
• V I volume of distribution of rapid-acting insulin [L]; 
• k e fractional elimination rate from plasma [1/min]. 
Out of these parameters, the following ones are time-varying:
 a,int , F 
s 
01 
, k 12 , EGP 0 , k b 1 , k b 2 , k b 3 , S IT , S ID , S IE , k a and k e [14, 25] . 
The model ( 1 ) could be extended with realistic sensor dynam-
cs; however this will not be addressed in this paper for reasons
f simplicity. CGM will be modeled with additive white noise. The
eason being is that the CGM signal has signiﬁcant random walk;
herefore, an advanced ﬁlter or estimator is needed to provide ac-
urate readings to the controller. This is not the scope of this paper,
ut effective methods can be found in [26, 39] . 
Six parameter sets representing six different virtual patients
ere available by the SimEdu in-silico simulator version 2.2, and
as been used in the paper for controller design and simulation.
imEdu represents one of the reference in-silico simulators in the
rtiﬁcial pancreas (AP) researches developed in accordance with
DA regulations [25] . 
. Controller design 
The H ∞ control methodology has been established for linear
ystems [20] . As T1DM models are nonlinear, an important issue is
he direct non-linearized applicability in the control scheme taking
he parameter inaccuracies into consideration as well. 
.1. LPV modeling 
There are several ways to handle the nonlinearity of the model.
he classical nonlinear methodology focuses on a differential geo-
etric approach [27] , while a more recent methodology is repre-
ented by linear parameter varying (LPV) systems [28–29] . 
LPV is an acceptable compromise between the model’s com-
lexity and the developed control algorithm, as LPV systems can be
een as an extension of linear time invariant (LTI) systems, where
he relations are considered to be linear, but model parameters are
ssumed to be functions of a time-varying signal [29] : 
˙ x(t) = A (ρ(t)) x (t) + B (ρ(t)) u (t) 
 (t) = C(ρ(t)) x (t) + D (ρ(t)) u (t) (2) 
here: 
 (ρ(t)) = 
m ∏ 
i =1 
ρi (t) A i B (ρ(t)) = 
m ∏ 
i =1 
ρi (t) B i (ρ(t)) = 
m ∏ 
i =1 
ρi (t) C i D (ρ(t)) = 
m ∏ 
i =1 
ρi (t) D i (3) 
It can be observed that ( 2 ) is an LTI system in the ρ( t ) schedul-
ng parameters; hence nonlinearity can be hidden and the A, B, C,
 matrices in ( 3 ) should be treated correspondingly during control
esign [29] . 
One approach could be the linearization around stable work-
ng points in the state-space, then creating a polytopic region of
ossible linear models, and using this information to determine
he nominal model and uncertainty weighting functions [23] . The
urrent paper can be considered as a continuation of the article
resented in [23] , in a more rigorous and complex manner. As in
23] only a given scenario was analyzed to present the capability
f LPV-modeling for T1DM control (i.e. for a given parameter set
 robust controller has been designed), here we give a complex
oadmap of the nonlinear robust control design for T1DM, analyz-
ng different parameter possibilities and highlighting the sensitivity
f uncertainty weighting function selection. Based on the gained
nowledge from real patient data collected from insulin pump cen-
ers (clinics and hospitals aﬃliated to the Hungarian Diabetes As-
ociation and considered the only legal entities in Hungary to work
ith CGMS and insulin pumps) we could formulate the weighting
unctions of the neglected uncertainties of the model. 
Beyond the polytopic representation, the other most widely
sed LPV-modeling approach exploits the aﬃne representation
similar to quasi-Aﬃne LPV) of the nonlinear model [30] . Given a
ounded vector ρ( t ) with bounded time-derivatives, the model can
e treated as a linear model with parameter inaccuracies. For the
odel ( 1 ) all candidates ρ( t ) (named as scheduling parameters)
re given in ( 4 ), being bounded ( 5-6 ) with their time-derivatives
s well [37] . Numerical values were determined analytically and
alidated with Monte-Carlo simulations [37] . 
(t) = 
(
Q 1 (t) 
F s 01 
Q 1 (t)+ V G Q 2 (t) x 1 (t) x 2 (t) 
)T 
(4) 
here: 
min = 
(
Q 1 , min 
F s 01 −F s 01 
Q 1 , max + V G Q 2 , min x 1 , min x 2 , min 
)T 
(5) 
max = 
(
Q 1 , max 
F s 01 +F s 01 
Q 1 , min + V G Q 2 , max x 1 , max x 2 , max 
)T 
(6) 
The existence of a qALPV model would make LPV-based control
ossible. From the proposed members of ρ( t ) parameters however
one can be measured; therefore, an LPV-based controller cannot
e implemented directly. Instead, the bounds should be used as
arameter inaccuracies of a linear model leading to two possible
pproaches: 
• Deﬁne an uncertain model directly; 
• Create input and output multiplicative uncertainties. 
For the current T1DM model the latter option was chosen eas-
ng the extension of unstructured uncertainties. Furthermore, the
ecision was inﬂuenced by the twelve time varying parameters of
he model ( k a,int , F 
s 
01 
, k 12 , EGP 0 , k b 1 , k b 2 , k b 3 , S IT , S ID , S IE , k a and k e
see Section 2 ). 
However, the choice of parameters for the qALPV-like descrip-
ion is not a trivial task. Finding the correct model can greatly re-
uce the burden on the controller, while choosing a wrong conﬁg-
ration could lead us to an overly complicated problem, where the
erformance of the controller could be similar to the performance
f a classical control strategy. 
Introducing μi ∈ [0, 1] ( i = 1 , . . . , 4 ) parameters to investi-
ate different conﬁgurations, while δi ∈ [0, 1] represent parame-
er inaccuracies, including the changing of scheduling parameter
202 L. Kovács / Knowledge-Based Systems 122 (2017) 199–213 
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Q  candidates, the state-space model of the system is described in
Appendix A in which  reﬂects the variation of the parameter un-
certainties (a variation of 5% was considered in each case as sug-
gested in [25] ). 
After evaluating all possible scenarios the conﬁguration ( μ1 , μ2 ,
μ3 , μ4 ) = (0, 0, 0, 0) was chosen. This means that state variables
x 1 ( t ) and x 2 ( t ), the remote effect of insulin on glucose distribution
and disposal, are not considered part of ρ( t ), while the switching
effect of the endogenous glucose production ( x 3 ( t )) is considered
as disturbance only. The reasons behind this choice are as follows:
• Although all of Q 1 ( t ), Q 2 ( t ), x 1 ( t ) and x 2 ( t ) states of the model
( 1 ) are bounded, the bounds of Q 1 ( t ) and Q 2 ( t ) only depend
on the performance of the controller. Smaller the glucose level
region the controller can keep, the smaller the parameter in-
accuracy of the model. On the other hand x 1 ( t ) and x 2 ( t ) are
bounded by the amount of injected insulin ﬂow. Higher the
maximal value of the possibly administered insulin, the faster
the controller disturbance compensation. Moreover, to avoid
hypoglycemia, zero insulin ﬂow is a possible scenario as well.
For better control properties, wider limits for the input are
needed, but at the same time the effect of parameter inaccu-
racies will also grow; 
• It can be easily demonstrated that μ1 = 0 will slow the dynam-
ics of Q 1 ( t ) in the nominal model, but at the same time the ef-
fect of the input will be the largest. On the other hand, μ1 = 1
would mean that the insulin concentration has no direct effect
on the plasma glucose levels; 
• The reason behind choosing μ3 = 0 and the effects of insulin on
Q 2 ( t ) is the same with μ1 and Q 1 ( t ) discussed previously; 
• In case of μ2 , choosing Q 1 ( t ) as parameter over x 1 ( t ) will leave
the insulin dynamics having an opposite effect on Q 2 ( t ) (the
rise in I ( t ) would increase the value of Q 2 (t)). Choosing a non-
zero value for μ2 however will lead to complex conjugate pole
pairs in the nominal model, with possibly instable dynamics
depending on the actual value of the ρ( t ) vector; 
• Choosing μ4 = 1 would deﬁnitely raise the effect of the injected
insulin on the controller, but the inaccuracy of the model would
also increase. Moreover, the controller has no information on
the fact that the state variable x 3 ( t ) and the endogenous glu-
cose production is connected. 
3.2. Weighting functions 
Weighting functions and unstructured uncertainty blocks rep-
resent effective tools to incorporate our a priori knowledge of
the controlled process into the model that is used for controller
design. Unstructured uncertainty blocks represent linear systems
with bounded norm ( H ∞ norm ≤1 in this particular case) and un-
known but stable and minimal phase dynamics [20] . Furthermore,
various constraints can be represented with weighting functions,
such as control signal limitations, tracking performance and dis-
turbance rejection. Once a model has been constructed in such
manner, computing the parameters of the corresponding controller
becomes a convex optimization problem. This is deﬁnitely one of
the greatest advantages of modern robust controllers and it re-
quires a deep understanding of the process dynamics (in our case
the T1DM) obtained mostly from measurements. In our case, the
gained knowledge and hence, the understanding of the diabetic pa-
tient behavior came from 83 patients’ more than 200 week contin-
uous glucose datasets analyzed throughout the years and collected
from the insulin pump centers of the Hungarian Artiﬁcial Pancreas
Working Group created in collaboration with the Hungarian Dia-
betes Association [40–41] . 
For classical control methods (e.g. PID) and nowadays fre-
quently used modern MPC method, synthesis is relatively easy forhe nominal model. However, when the above mentioned con-
trains, uncertainties and disturbances are present satisfying all of
hem is impossible (e.g. PID controller) or requires solving non-
inear optimization tasks with demanding numerical methods (e.g.
PC). A working controller can be implemented nevertheless, but
afety cannot be guaranteed. 
Using the parameter inaccuracy information and the LPV-model
onstructed above, uncertainty weighting functions can be deter-
ined. There are altogether four of these functions: W in (s), W 1 (2),
 2 (s) and W out (s) . The transfer functions were determined based
n gridding technique and upper approximation of the frequency
esponses obtained, similar to [31] . The results are based on the
ix patients’ simulations of SimEdu in-silico simulator [25] . 
W in (s) represents the uncertainty of the dynamics of the sub-
ystem (denoted as G 1 (s) later) of ( 1 ) consisting of the state vari-
bles S 1 (t), S 2 (t) and I(t) . Its transfer function is presented in ( 7 ),
hile the amplitude spectrum is displayed in Fig. 1 . At smaller fre-
uencies, the uncertainty remains 5.5%, while it rises up to 22% for
requencies larger than 0.1 rad/min [31] . 
 in (s ) = 0 . 055 
101 . 01 s + 1 
25 . 31 s + 1 (7)
W 1 (s), W 2 (s) represent the uncertainty of x 1 ( t ) Q 1 ( t ) and
 2 ( t ) Q 2 ( t ) output of the subsystem containing state variables x 1 (t),
 2 (t) and x 3 (t) (referred to as G 2 (s) ). This includes the effect of
he changing parameters and the change of the selected schedul-
ng parameters. The chosen transfer functions of these weights are
resented in ( 8 ), while their amplitude spectrum is displayed in
ig. 2 and Fig. 3 . All values were determined by the same grid-
ing technique [31] , except that here both model parameter and
cheduling parameter changes were considered. W 2 (s) is signiﬁ-
antly larger than W 1 (s) since x 2 (t) varies in wider range. Further-
ore, the parameters of W 2 (s) are different for each of the six pa-
ient of SimEdu [25] , while one common W 1 (s) is used. K, T and τ
re parameters . 
 1 (s ) = 0 . 536 714 s + 1 
624 s + 1 
 2 (s ) = K τ s + 1 
T s + 1 (8)
Finally W out (s) was chosen as presented in ( 9 ) and Fig. 4 . In
he subsystem ( G 1 (s) ) consisting of state variables C(t), Q 1 (t) and
 (t) there are various uncertain parameters, a scheduling variable,2 
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o  s well as a kind of switching effect because of renal clearance:
 cl max { 0 , Q 1 (t) − R thr V G } . The other switching component repre-
enting endogenous glucose production ( EG P 0 max { 0 , 1 − x 3 (t) } ) is
reated as noise in accordance with what was presented earlier as
ained knowledge about the nominal model. On higher frequencies
he amplitude goes up to one, which represents 100% uncertainty.
his represents the assumption that we have no reliable informa-
ion on the behavior of the system on frequencies close to the sam-
ling frequency; furthermore there might be neglected dynamics.
 out (s ) = 0 . 15 100 s + 1 
1 5 s + 1 (9)
The disturbances also require weighting functions. W m (s) for
he glucose ﬂux from the gut is created using the meal absorption
odel presented in [25] . Although it is nonlinear in the original
odel, a worst case representation is possible with a second order
inear system: 
 m (s ) = U G,ceil 
( t max s + 1 ) 2 
(10) 
here U G,ceil is the maximum glucose ﬂux from the gut
mmol/kg/min], while t max is the time-to-maximum appearance
ate of glucose in the accessible compartment [min]. 
The effect of physical activity does not need an additional
omponent aside from a corresponding input. The measurement
oise has a constant weighting function: W n = 0.5 representing
.5 mmol/L standard deviation of the measurement noise [37] . 
The constraints on the control signal can also be captured with
 weight. It can be either constant with value W u = u −1 max , or we
an also restrict fast changes with a transfer function presented in
ig. 5 . Limiting the control signal on higher frequencies can pre-
ent rapid oscillations. 
Finally, we have to deﬁne the desired tracking performance
ith a weighting function denoted as W p (s) . Using our gained
nowledge in the ﬁeld [37, 42] , our choice in this particular case
s presented by a ﬁrst order system given in ( 11 ). The numerical
alues are different for every controller, but the structure remains
he same in a sense that the requirements are different for lower
nd higher frequencies. The former drives the glucose concentra-
ion towards the normoglycemic range, while the latter gives more
elaxed bounds on rapid changes. This is in accordance with the
ncertainty of the model in high-frequency regions. Furthermore,
scillations and hypoglycemic episodes can be reduced at the cost
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Table 1 
Parameters of performance weighting functions. 
Controller T τ K 
Regular (low γ ) 300 9 .6774 0 .031 
Regular (high γ ) 350 7 .7778 0 .045 
Integral (low γ ) 400 40 0 .01 
Integral 300 30 0 .05 
2DoF (low γ ) 400 16 0 .025 
2DoF (high γ ) 300 30 0 .05 
Integral 2DoF (low γ ) 400 40 0 .01 
Integral 2DoF (high γ ) 300 30 0 .05 
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Fig. 6. Example for complete weighting functions of W int (s) and W p (s) . 
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 p (s ) = K τ s + 1 
T s + 1 (11)
The numerical values for each controller are summarized in
Table 1 . Note that there are two versions for each controller. The
reasons will be explained later in Section 3.3 . 
As an example, choosing 0.5 for low frequencies means that the
residual tracking error should be lower than 2 mmol/L even in the
most extreme case. 
In classical control theory PID control or controllers containing
an integrator can effectively eliminate residual error, which is a
useful property when dealing with uncertain systems. However, in
H ∞ , control performance weighting functions cannot contain inte-
grator, for it has inﬁnitely large H ∞ norm, but we can make it part
of the model in a different manner (as shown later in Fig. 10 and
Fig. 12 ). In this case, the additional W int (s) component could be de-
ﬁned with a transfer function given in ( 12 ), determined on the re-
sponses of the SimEdu virtual simulator [25] . The output of W int (s)
must be made available for measurement. The series of this ele-
ment with the performance weight function W p (s) can result in an
amplitude spectrum similar to the illustration presented in Fig. 6 .
 int (s ) = 
10 0 0 s + 1 
10 0 0 s 
(12)
Furthermore, a two degree of freedom (2DoF) control structure
is also possible. In order to achieve this, we require a reference
system W track (s) . Instead of following a reference signal directly,
the aim was to match the behavior of the controlled system to
the reference system. In case of a classical 2DoF control the con-
troller consists of a feed-forward and feedback component, wherehe former acts as a ﬁlter of the reference signal. Since the refer-
nce signal in this case is constant, the feed-forward component is
ot needed. 
However, we do require an adequate estimation of the distur-
ances affecting the model, for which the reference model re-
ponds with desired behavior. Hence, the controller in the 2DoF
odel will provide an estimation of the output of W m (s) with
stimation error constrained by weighting function W d (s) . Only the
eal disturbance was considered, since this has the most signiﬁ-
ant impact on the blood glucose levels among the processes that
lways elevate the glucose concentration. Endogenous glucose pro-
uction is assumed to change rapidly because of the switching ef-
ect; hence, it is diﬃcult to observe in these settings. The trans-
er functions of W track (s) and W d (s) are presented in ( 13 ) and dis-
layed on Fig. 7 and determined on simulations of SimEdu’s re-
ponses (based on all the responses an upperbound function was
etermined empirically). Note that the output of W m (s) is divided
y U G before entering W d (s) . 
 track (s ) = 
76500 s 
30 0 0 s 2 + 310 s + 1 
W d (s ) = 0 . 75 
2 . 86 s + 1 
215 s + 1 (13)
.3. Controller structure 
The controller structures for regular controller, integral control,
DoF control and 2DoF with integrator are presented on Fig. 8 in-
luding all the uncertainty weighting functions determined above.
he components with solid line are common for all types and
he weighting functions described above. In case of 2DoF control,
he elements drawn with dashed line should be also taking into
ccount, including the tracking performance weighting function
 p (s) , the W d (s) for output estimation of W m (s) and the reference
ystem W track (s) . Dotted line marks the parts that belong to inte-
ral control ( W int (s) and a separate tracking performance function
 p (s) ), as opposed to the semi-dotted elements that are present
nly in the absence of the integrator. 
The components W in (s), W 1 (s), W 2 (s), W out (s), W m (s), W n (s),
 u (s), W p (s), W int (s), W d (s) and W track (s) were introduced previ-
usly. G 1 (s), G 2 (s) and G 3 (s) stand for the subsystems described
hen the uncertainty weighting functions were presented. The
ontroller provides the injected insulin control signal u(t) and es-
imated disturbance ˆ d (t) in the 2DoF case. The disturbances are
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u(t)
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Fig. 8. Considered structures of the H ∞ controllers. 
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0.18
0.2
Am
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itu
de
5.5 > Q1(t)/VG > 4.5he ingested meal d(t) , effect of physical activity phy (t), sensor
oise n(t) , and the disturbance resulting from endogenous glucose
roduction EGP(t). z e ( t ) and z u ( t ) are outputs of the performance
eighting functions, while z d1 ( t ) and z d2 ( t ) keep the disturbance
stimation in check. y ( t ) is the measured output of the system. 
Note that the reference signal cannot be found in Fig. 8 . The
eason is that the reference signal is constant, and no constant
nput of the model has signiﬁcance when designing a linear dy-
amic system. The offset caused by the reference signal, or other
lements of the model is compensated by the integrator if present,
therwise an additional constant input is needed. 
An additional safety feature has been included in all controllers.
henever the measured blood glucose concentration reaches a
ertain lower limit (4.5 mmol/L), the control signal will be set as
ero. This is a frequently used method in recent insulin pumps
voiding or reducing certain hypoglycemic episodes. The controller
ould be tuned to avoid these episodes without using this feature,
f the uncertainty of the model would not be this high. However,
he reason of high uncertainty used in this paper was to iterate
n the possibilities in modern robust controller design, giving a
oadmap of it. 
The controllers were implemented using Robust Control Tool-
ox of MATLAB 2009b. 10−3 10−2 10−1 100
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Fig. 9. Frequency characteristic of the weighting function W 3 (s) . The current case study highlights the diﬃculties in order to as-
ure robust performance (RP), i.e. an H ∞ norm smaller than one
or the transfer matrix of the closed loop system. This can only
e satisﬁed by deﬁning weak tracking performance, inadequate to
eep the plasma glucose concentration of the patient in the nor-
oglycemic range. 
Therefore, two different versions were considered for each con-
roller: one where RP is met and one where only robust stability
RS) is assured. The latter has stricter performance speciﬁcations,
hich are not met, but closed loop stability is still ensured. (Need-
ess to say, a true solution would reduce the uncertainties of the
ystem, but this cannot be done with a linear controller.) 
One very important feature of this control strategy is that no in-
ormation regarding the occurrence and size of meals is provided,10−4 10−3 10−2 10−1
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Fig. 10. Weighting functions of W 1 (s) in switching controller. 
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Fig. 11. Weighting functions of W 2 (s) in switching controller. 
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W  unlike many other methods found in the literature. This certainly
leaves a great burden on the controller, but makes it signiﬁcantly
less dependent from the compliance of the patient and approaches
better the real life situation of a diabetic patient. 
3.4. Switching control 
A more effective approach can take into consideration the
"switching" nature of the model. Endogenous glucose production
( EGP ) and renal clearance ( R cl ) represent linear dependencies in
certain working points, and non-existent in others. Treating each
case separately four different models can be deﬁned requiring four
different controllers. Each model has slightly different dynamics,
but individually they impose less burden on the respective con-
trollers. Furthermore, based on the blood glucose levels more mod-
els can be deﬁned, similar to [32] . The six considered models are: • No EGP(t) and Q 1 ( t ) ∈ [4.5 · V G , 5.5 · V G ] (no renal clearance); 
• EGP(t) is active, Q 1 ( t ) ∈ [4.5 · V G , 5.5 · V G ] (no renal clearance);
• No EGP(t) and Q 1 ( t ) ∈ (5.5 · V G , R th V G ] (no renal clearance); 
• EGP(t) is active, Q 1 ( t ) ∈ (5.5 · V G , R th V G ] (no renal clearance); 
• No EGP(t) and Q 1 ( t ) > R th V G (renal clearance active); 
• EGP(t) is active, Q 1 ( t ) > R th V G (renal clearance active). 
Unfortunately the state variables that could be used to perform
he switching cannot be measured, only estimated. The structure of
he nominal model and the controllers are the same as previously,
xcept that EGP(t) is not a disturbance anymore, but part of the
ystem. This calls for an additional uncertainty weighting function
 3 (s) given in ( 14 ), which incorporates the parameter changes of
 b3 and S IE ( Fig. 9 ). Similarly to W 1 (s) and W 2 (s) the parameters of
 3 (s) were determined by gridding technique [31] . 
 3 (s ) = 0 . 0627 17 . 7904 s + 1 
11 . 468 s + 1 (14)
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Table 2 
Parameters of performance weighting functions for switching controllers. 
Controller T τ K 
Regular (4.5 < Q1(t)/V G ≤5.5) (low γ ) 300 37.5 0.04 
Regular (5.5 < Q1(t)/V G ≤R th ) (low γ ) 300 50 0.03 
Regular ( R th < Q1(t)/V G ) (low γ ) 300 33.33 0.045 
Regular (4.5 < Q1(t)/V G ≤5.5) (high γ ) 300 6 0.05 
Regular (5.5 < Q1(t)/V G ) (high γ ) 300 5 0.06 
Integral (low γ ) 400 40 0.01 
Integral (4.5 < Q1(t)/V G ≤5.5) (high γ ) 300 30 0.05 
Integral (5.5 < Q1(t)/V G ≤R th ) (high γ ) 300 25 0.06 
Integral ( R th < Q1(t)/V G ) (high γ ) 300 21.43 0.07 
2DoF (4.5 < Q1(t)/V G ≤5.5) (low γ ) 300 9.375 0.032 
2DoF (5.5 < Q1(t)/V G ≤R th ) (low γ ) 300 10 0.03 
2DoF ( R th < Q1(t)/V G ) (low γ ) 300 8.57 0.035 
2DoF (high γ ) 300 12 0.05 
Integral 2DoF (4.5 < Q1(t)/V G ≤5.5) (low γ ) 300 30 0.01 
Integral 2DoF (5.5 < Q1(t)/V G ≤R th ) (low γ ) 400 40 0.01 
Integral ( R th < Q1(t)/V G ) 2DoF (low γ ) 300 12 0.025 
Integral 2DoF (4.5 < Q1(t)/V G ≤5.5) (high γ ) 300 30 0.05 
Integral 2DoF (5.5 < Q1(t)/V G ≤R th ) (high γ ) 300 7.5 0.04 
Integral 2DoF ( R th < Q1(t)/V G ) (high γ ) 300 23.077 0.065 
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wBy the mentioned considerations on switching, the uncertainty
ill be reduced for certain components of the model. Furthermore
ifferent weighting functions can be deﬁned for different working
oints and also for different patients. W 1 (s) differs depending on
he value of Q 1 (t) resulting in three different weights given as fol-
ows ( Fig. 10 ). 
 1 ( s | 4 . 5 < Q 1 ( t ) V G ≤ 5 . 5 ) = 0 . 15 714 . 286 s + 1 
51 5 . 724 s + 1 (1 5)
 1 ( s | 5 . 5 < Q 1 ( t ) V G ≤ R th ) = 0 . 41 714 . 286 s + 1 608 . 415 s + 1 (16) 
 1 ( s | R th < Q 1 ( t ) V G ) = 0 . 103 714 . 286 s + 1 464 . 28 s + 1 (17) 
Based on the remarks given at W 2 (t) selection, i.e. the param-
ters of W 2 (s) are different for each of the six patient of SimEdu
see Eq. (8) and Fig. 3 ), for every switching case a corresponding
requency evaluation of W 2 (t) is required ( Fig. 11 ). 
On the other hand, based on ( 9 ), the W out (s) weighting function
epresents smaller uncertainty on lower frequencies ( Fig. 12 ). 
 out (s ) = 0 . 02 2 . 05 s + 1 
100 s + 1 (18) 
Three mostly different performance weighting function were
etermined for every controller depending on the value of Q 1 (t) .
he controllers could further be tuned by deﬁning different W p foru(t)
zu(t)
d(t)
phy(t)
dˆ(t)
−
Wu
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Win Δ
G2
W3 Δ
W2
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Wm
Δ
Δ
Wd
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Fig. 13. Considered structures of thvery working point. The parameters are summarized in Table 2 .
he time constant ( T ) is selected on the model property (only in
ase of integral control is used a higher time due to meal absorp-
ion), K and τ are results of the weighting functions selected. 
Similarly to the non-switching case, two different versions have
een implemented for each type of controllers: one where RP is
atisﬁed and one where only RS is true. The structures of all four
witching controllers are presented in Fig. 13 (similar to Fig. 8 , just
hat here the uncertainty weighting function W 3 (s) is included in
ddition for the endogenous glucose production part), where the
ine-style of the different elements is the same as in the non-
witching case. The components with solid line are common for
ll types. In case of 2DoF control, the elements drawn with dashed
ine should be also taken into account. Dotted line marks the parts
hat belong to integral control, as opposed to the semi-dotted ele-
ents that are present only in the absence of the integrator. 
All six controllers were implemented and ran in parallel. The
ontrol signal will be the weighted sum of all controller outputs.
he weights are determined using sigmoid functions to avoid rapid
hanges in the signal during switching. For a controller that is valid
hen Q 1 ( t ) ∈ [ Q 1 ,i , Q 1 ,i ] and x 3 ( t ) ∈ [ x 3 ,i , x 3 ,i ] the weight ˜ wi will be
etermined as follows: 
 i = 
1 
1 + exp 
(
M 
(
Q 
1 ,i 
− Q 1 ( t ) 
)) 1 
1 + exp 
(
M 
(
Q 1 ( t ) − Q 1 ,i 
))zd,2(t)
zd,1(t)
− −
n(t)
ze(t)
y(t) y(t)
ze(t)
Wout Δ
Wtrack
Wn
Wp
Wint Wp
e switching H ∞ controllers. 
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Fig. 14. Control variability grid analysis for controllers without switching (low γ ). 
Fig. 15. Control variability grid analysis for controllers without switching (high γ ). 
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Fig. 16. Simulation over time for non-switching H ∞ controller (low γ ). “Measured” repr
system, while “reference” is for the output of the reference system W track . × 1 
1 + exp 
(
M 
(
x 3 ,i − x 3 ( t ) 
)) 1 
1 + exp ( M ( x 3 ,i − x 3 ( t ) ) ) 
(19)
˜ 
 i = 
w i 
6 ∑ 
j=1 
w j 
(20)
The control signal is considered zero when the lower threshold
f the measured glucose concentration (4.5 mmol/L) is reached. 
Compared to the non-switching case, smaller γ values could
e achieved for the same performance functions. On the other
and, the synthesis could become numerically badly conditioned
hen faster tracking properties have been enforced. Furthermore,
he poles of the controller could grow too high, resulting in slow
imulations. Consequently, balanced model reduction was neces-
ary [20] . 
. Simulation results 
Altogether eight different controllers were implemented and
ested using the University of Cambridge Simulator educational
ersion 2.2 (SimEdu) [25] . 
In case of integral control RP was not possible to be achieved
ith merely reducing the weighting of the tracking performance,
nd not even RS could be ensured in certain cases. Results include
assive hypoglycemic episodes during simulation, which suggests
hat unless the uncertainty is reduced, or additional information is
ade available regarding the disturbances (e.g. meal intake), inte-
ral control is not favorable for H ∞ control of this model. However,
or H 2 or L 1 control the idea might be more effective [20] . PID con-
rol is extensively researched for the AP problem [8, 13] , therefore30 36 42 48
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Fig. 17. Simulation over time for non-switching H ∞ controller (high γ ). “Measured” represents the signal measured by the CGM sensor, “real” stands for the output of the 
system, while “reference” is for the output of the reference system W track . 
Fig. 18. Control variability grid analysis for switching controllers (low γ ). 
Fig. 19. Control variability grid analysis for switching controllers (high γ ). 
Table 3 
Summary of meal intake simulation parameters. 
Meal type Chance of occurrence Amount (g CHO) Time 
Breakfast 100% 50 – 90 g 6 :00 – 10:00 
Snack 1 50% 10 – 50 g 8 :00 – 11:00 
Lunch 100% 60 – 120 g 11 :00 – 15:00 
Snack 2 50% 10 – 30 g 15 :00 – 18:00 
Dinner 100% 35 – 95 g 18 :00 – 22:00 
Snack 3 50% 10 – 20 g 22 :00 – 24:00 
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s  xtending the controller with an integrator could be considered for
obust methods as well. 
Six virtual patients of the SimEdu in-silico simulator were used
nd 100 simulations were conducted for each patient with ran-
omized initial states, parameter change, meal and physical ac-
ivity proﬁle. Uniform distribution was used in all cases. Table 3
ummarizes the parameters of meal intakes. Physical activity oc-
ured 50% of the time starting between 9:0 0–12:0 0 and lasting for
–4 hours. It can be seen from Table 3 that based on the rela-
ively wide ranges of meal intake possibilities (simulating in this
ay the uncertain carbohydrate (CHO) estimation of the patients)
ven exterme meal intakes (400 g CHO) can occur. Moreover, by
he uncertain time intervals the idea was to deal with the uncer-
ain registration of the meal periods as well. 
For all simulations a complete 48 hours simulation time inter-
al was considered. The simulation results were evaluated based
n the international standards of control variability grid analysis
CVGA) [33] and are presented below. 
Figs. 14–17 shows the analysis for the switching and non-
witching cases separating the case when only RP (low γ ) or when
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Fig. 20. Simulation over time for switching H ∞ controller (low γ ). “Measured” represents the signal measured by the CGM sensor, “real” stands for the output of the system, 
while “reference” is for the output of the reference system W track . 
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 only RS (high γ ) is satisﬁed. Instead of mmol/L the results are pre-
sented in the more widely used mg/dL format, for easier compari-
son. 
Fig. 14 reﬂects the non-switching robust control results. It can
be seen that taking the uncertain meal intake or time recording
into account, for scenarios presented in Table 3 eﬃcient and gen-
erally robust control cannot be achieved. 
This result clearly presents the pros and cons of modern ro-
bust control methodology. Only guaranteeing RP does not mean
that one could obtain a suitable controller. It is true that the con-
troller achieved is generally applicable, but in a physiologically un-
acceptable range: big oscillations with big number of hypo- and
hyperglycemic episodes that endanger diabetic patients’ life. 
This remark is true for focusing on RS as well ( Fig. 15 ). More-
over, results in Fig. 15 demonstrate illustratively that RS is “below”
in quality requirements than RP. Simulations over time are exem-
pliﬁed by Figs. 16 and 17 for both (RP and RS) cases. 
In conclusion, it can be mentioned that for an individualized
/ personalized control (MPC or other methods used in the liter-
ature [13–19] ) discussion is needed to adapt the problem on the
given patient’s characteristics, which however is not robust enough
(it cannot handle Table 3 scenarios); hence, the two approaches
should be combined. In other words, an adequate choice for the AP
problem could be envisaged using a hierarchical control structure
(not the scope of the current paper): individualized control solu-
tion adapted to the patient’s physiology placed in a robust control
framework to guarantee RP even for the worst cases. 
By the switching control scheme ( Fig. 18 ) the above mentioned
remarks are true as well, but a qualitatively increased performance
can be observed. RP is better matched with the physiological ex-
pectations due to the different working regimes where the con-
 roller is able to satisfy more adequately the physiological require-
ents. Results are still not the best, but due to the considered un-
ertain and extreme scenarios of Table 3 most of the hypoglycemic
vents (most dangerous for T1DM patients) can be avoided, while
emaining ones are only moderate. 
Regarding hyperglycemia, a considerable drop in CVGA from the
esults presented in Figs. 14 and 15 can be observed. Moreover,
ue to the high meal intake scenarios it is expected to have high
lucose levels for T1DM patients. However, a hierarchical control
tructure mentioned above could better tune the results. Focusing
nly on RS ( Fig. 19 ) the same remarks can be concluded as in the
on-switching cases: although RS can be guaranteed, without sat-
sfying the nominal performance requirements (in our case mini-
izing hypoglycemia) the control quality is worse. 
In the switching cases, simulations over time are exempliﬁed by
igs. 20 and 21 again for both (RP and RS) cases. In case of 2DOF
ontrol, the reference signal is also displayed. 
Table 4 summarizes the simulation results for all the eight con-
idered controller structures. 
Analyzing these results, the following remarks can be made: 
• The controllers achieved are not ideal ones, but they are able
to prove their robust characteristics. With the extreme scenar-
ios considered they guaranteed RP (or RS). In this way, a hier-
archical control solution with individualized control adapted to
the patient’s physiology placed in a robust control framework
to guarantee RP even in the worst cases can be a real alterna-
tive for the AP problem. 
• For higher γ values, when only RS is met, blood glucose lev-
els usually do not go as high when RP is satisﬁed. However,
this comes at the cost of higher possibility for hypoglycemic
episodes. 2DoF control can slightly shorten the duration of hy-
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Fig. 21. Simulation over time for switching H ∞ controller (high γ ). “Measured” represents the signal measured by the CGM sensor, “real” stands for the output of the system, 
while “reference” is for the output of the reference system W track . 
Table 4 
Summary of simulation results for all controller types. 
Controller Hypo < 4 mmol/L Norm 4–6 mmol/L Mild hyper 6–7.8 mmol/L Hyper 6–11.1 mmol/L Severe hyper > 11.1 mmol/L 
without switching 
Regular (low γ ) 6 .68% 25 .98% 10 .11% 26 .67% 40 .66% 
Regular (high γ ) 13 .40% 28 .34% 12 .51% 30 .03% 28 .23% 
2DoF (low γ ) 3 .13% 23 .24% 9 .01% 23 .00% 50 .63% 
2DoF (high γ ) 10 .75% 26 .93% 11 .87% 30 .42% 31 .90% 
with switching 
Regular (low γ ) 5 .35% 27 .02% 8 .14% 24 .45% 43 .17% 
Regular (high γ ) 11 .39% 28 .83% 9 .13% 26 .46% 33 .33% 
2DoF (low γ ) 4 .59% 25 .49% 6 .78% 21 .28% 48 .64% 
2DoF (high γ ) 10 .41% 28 .33% 8 .32% 25 .14% 36 .13% 
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i  poglycemic episodes. It might be more favorable to provide dis-
turbance estimation with a more capable tool, e.g.: Kalman ﬁl-
ters or their extensions on sigma-point ﬁltering [39, 42] . 
• Switching control could considerably improve the results by
deﬁning different working regimes where the controller could
focus only on the given regimes’ particularities. In this con-
text we have designed the corresponding controller used in our
robust control framework. Results were presented in [37] and
Fig. 22 illustrates a simulation result of the system, where the
shortcomings presented in the above roadmap were avoided. 
. Conclusions and further research directions 
In this case study, the implementation of H ∞ controllers were
nvestigated for the widely known and used T1DM model pub-
ished in [10] and later updated in [25] . From the nonlinear model
 nominal linear system was constructed with weighting functions
epresenting the nonlinearity and parameter inaccuracies gainedrom expertise collected from real diabetic patient measurements
r simulations of the validated SimEdu virtual simulator [25] . Us-
ng this conﬁguration, regular, integral, 2DOF and integral 2DOF
 ∞ robust controllers were implemented; both for switching and
on-switching case. Simulations were conducted using 6 virtual
atient data. 
The study intended to show the possible issues appearing in
 ∞ controller design for this particular artiﬁcial pancreas prob-
em. The exact mathematical formulation of modern robust tech-
ique was combined with the empirical (knowledge-based) exper-
ise gained from medical practice. The most practical issues have
een addresses and results have been tested for extreme scenar-
os (high meal intakes and uncertain time recording). Switching
ontrol possibilities have been presented. Beside the robust control
esign roadmap given in the paper, the advantage of the research
rom control engineering point of view is to present the sensitiv-
ty of uncertainty weighting function selection, demonstrating that
212 L. Kovács / Knowledge-Based Systems 122 (2017) 199–213 
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 without given expertise (in this case medical knowledge) not only
robust, but even unstable solution can be achieved. From clinical
point of view the clear advantage is that once a robust controller
is designed, there is no need to be redesigned on different patients
or treatment scenarios; however, several medical data are needed
increasing the knowledge required to achieve the robustness prop-
erty. 
Future research will focus on solving the H ∞ controller design
on the investigated model using LPV modeling methodology, but
also extended to a generalized LPV approach of Tensor Product
model transformation [43–44] . Since the scheduling parameters
cannot be measured directly, accurate estimation is needed and
the resulting error must be considered and incorporated into the
nominal model formulation [45–49] . Furthermore, H 2 and L 1 ro-
bust controllers can be implemented and compared with the ones
presented in this paper. Hybrid controllers satisfying multiple con-
straints or hierarchical control structure combining individualized
control strategies with modern robust methods are an option as
well. Practical issues, such as sensor dynamics, errors and insulin
pump failures should also be addressed together with other opti-
mization methods e.g. [34–35, 42] . As a ﬁnal remark it is impor-
tant to mention that the aim of modern robust control is not to
compete with individualized methodologies (like MPC), but to eﬃ-
ciently extend them giving extra safety guarantees. 
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Appendix A 
The state-space representation of the T1DM model using the
switching control and scheduling parameter combinations. 
A 1 , 1 = −k a, int − δ1 k a, int 
A 1 , 2 = 
k a, int 
V 
+ δ2 
k a, int 
V G G  2 , 2 = −
ρ4 , max + ρ4 , min 
2 
μ1 − ( 
ρ2 , max + ρ2 , min ) 
2 
− R cl 
2 
−δ3 
ρ4 , max − ρ4 , min 
2 
μ1 − δ4 ( 
ρ2 , max − ρ2 , min ) 
2 
− δ5 R cl 
2 
 2 , 3 = k 12 + δ6 k 12 
 2 , 4 = − ( 
ρ1 , max + ρ1 , min ) 
2 
( 1 − μ1 ) − δ7 ( 
ρ1 , max + ρ1 , min ) 
2 
( 1 − μ1 )
 2 , 6 = −μ4 E G P 0 + E G P 0 
2 
− δ8 μ4 E G P 0 + E G P 0 
2 
 3 , 2 = 
ρ4 , max + ρ4 , min 
2 
μ2 + δ3 
ρ4 , max − ρ4 , min 
2 
μ2 
 3 , 3 = −k 12 − δ6 k 12 −
ρ5 , max + ρ5 , min 
2 
μ3 − δ9 
ρ5 , max − ρ5 , min 
2 
μ3 
 3 , 4 = ( 
ρ1 , max + ρ1 , min ) 
2 
( 1 − μ2 ) − δ7 ( 
ρ1 , max + ρ1 , min ) 
2 
( 1 − μ2 ) 
 3 , 5 = − ( 
ρ3 , max + ρ3 , min ) 
2 
( 1 − μ3 ) − δ10 ( 
ρ3 , max + ρ3 , min ) 
2 
( 1 − μ3 )
 4 , 4 = −k b1 − δ11 k b1 
 4 , 7 = S IT k b1 + δ12 ( S IT k b1 + S IT k b1 + S IT k b1 ) 
 5 , 5 = −k b2 − δ13 k b2 
 5 , 7 = S ID k b2 + δ14 ( S ID k b2 + S ID k b2 + S ID k b2 ) 
 6 , 6 = −k b3 − δ15 k b3 
 6 , 7 = S IE k b3 + δ16 ( S IE k b3 + S IE k b3 + S IE k b3 ) 
 7 , 7 = −k e − δ17 k e 
 7 , 8 = k a 
V I 
+ δ18 k a 
V I 
 8 , 8 = −k a − δ18 k a 
 8 , 9 = k a + δ18 k a 
 9 , 9 = A 8 , 8 
B 2 , 1 = B 9 , 2 = C 1 , 1 = 1 , otherwise 0 
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